DexCom (DXCM) stock has been in focus after Investor Day communications that many fund managers say improved sentiment, ...

Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announces that DBLG2 ...

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the ...

Insulet has launched its Omnipod 5 Automated Insulin Delivery System and Omnipod Discover data management platform in Spain, expanding its European footprint ...

Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...

DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter and fiscal year ended December 31, 2023. Fourth Quarter 2023 Financial Highlights: Revenue ...

Omnipod 5 Automated Insulin Delivery System now available in 20 countries worldwide New web-based data platform Omnipod Discover simplifies diabetes insights for users, caregivers, and healthcare ...

Insulet Corporation PODD has commercially launched its Omnipod 5 Automated Insulin Delivery (AID) system and the Omnipod ...

The Omnipod 5 with an iPhone [Image courtesy of Insulet] Insulet (Nasdaq:PODD) announced today that it launched its Omnipod 5 insulin pump and Omnipod Discover platform in Spain. With the launch, ...

Diabetes technology news has been off to a fast start this year. Here are some highlights of MedTech Dive’s coverage from ...

The newly approved over-the-counter CGM offers a new approach to tackling childhood obesity but also raises a host of ...

Insulet Corporation (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced the commercial launch of its Omnipod 5 ...